Impact of Early Lung Physiology, Viral Infections and the Microbiota on the Development and Progression of Lung Disease in Children With Cystic Fibrosis

This study collects data on microbiological factors and lung function parameters (e.g. spirometry, body plethysmography, lung-MRI) to assess their interaction on the lung growth and lung development of infants and children with Cystic Fibrosis (CF).

NCT Number	NCT04026360
Lead Sponsor	Insel Gruppe AG, University Hospital Bern Collaborators: University Children's Hospital, Zurich, Centre Hospitalier Universitaire Vaudois, Kantonsspital Aarau, University Children's Hospital Basel
Conditions	Confirmed Diagnosis of Cystic Fibrosis
Enrollment	500 participants
Start Date	2011-07-01
Primary Completion	2050-08-31 (estimated)
Study Completion	2050-12-31 (estimated)
Updated on ClinicalTrials.gov	2020-11-04